Regeneron Pharmaceuticals
REGN
$828.10
Share price
-0.42%
Change (1 day)
17.59%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) Fails to deliver data
Key failure to deliver metrics for Regeneron Pharmaceuticals:
- Last SEC data release: 2023-07-31
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $37.09 M
- Last year FTD volume: $0.11 B
Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013
Volume in USD (price x number of shares), data since 2013Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $72.96 M | -42.33% |
| 2022 | $0.12 B | -53.05% |
| 2021 | $0.26 B | 5.23% |
| 2020 | $0.25 B | 414.86% |
| 2019 | $49.73 M | -31.98% |
| 2018 | $73.11 M | 69.52% |
| 2017 | $43.12 M | -78.72% |
| 2016 | $0.20 B | 3.03% |
| 2015 | $0.19 B | -15.29% |
| 2014 | $0.23 B | 419.89% |
| 2013 | $44.67 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.30 B | $0.50 B | 🇺🇸 USA |
 Novartis NVS | $10.06 M | $52.33 M | 🇨🇭 Switzerland |
 Amgen AMGN | $22.23 M | $0.31 B | 🇺🇸 USA |
 Sanofi SNY | $8.99 M | $87.65 M | 🇫🇷 France |
 Biogen BIIB | $29.51 M | $74.91 M | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $0.62 M | $0.12 B | 🇺🇸 USA |